-
1
-
-
84860349448
-
Aphase 1/2 study of chemosensitization with the CXCR4 antagonist plerixa for in relapsed or refractory acute myeloid leukemia
-
Uy GL, Rettig MP, Motabi IH, et al. Aphase 1/2 study of chemosensitization with the CXCR4 antagonist plerixa for in relapsed or refractory acute myeloid leukemia. Blood. 2012;119(17):3917-3924.
-
(2012)
Blood
, vol.119
, Issue.17
, pp. 3917-3924
-
-
Uy, G.L.1
Rettig, M.P.2
Motabi, I.H.3
-
2
-
-
0033524834
-
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
-
Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283(5403):845-848.
-
(1999)
Science
, vol.283
, Issue.5403
, pp. 845-848
-
-
Peled, A.1
Petit, I.2
Kollet, O.3
-
3
-
-
0141923918
-
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
-
DOI 10.1182/blood-2003-02-0663
-
Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102(8):2728-2730. (Pubitemid 37248839)
-
(2003)
Blood
, vol.102
, Issue.8
, pp. 2728-2730
-
-
Liles, W.C.1
Broxmeyer, H.E.2
Rodger, E.3
Wood, B.4
Hubel, K.5
Cooper, S.6
Hangoc, G.7
Bridger, G.J.8
Henson, G.W.9
Calandra, G.10
Dale, D.C.11
-
4
-
-
0037777665
-
Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells
-
Christopherson KW 2nd, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003; 101(12):4680-4686. (Pubitemid 36857720)
-
(2003)
Blood
, vol.101
, Issue.12
, pp. 4680-4686
-
-
Christopherson II, K.W.1
Cooper, S.2
Broxmeyer, H.E.3
-
5
-
-
13744255245
-
CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice
-
DOI 10.1158/0008-5472.CAN-03-3693
-
Tavor S, Petit I, Porozov S, et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res. 2004;64(8):2817-2824. (Pubitemid 38500620)
-
(2004)
Cancer Research
, vol.64
, Issue.8
, pp. 2817-2824
-
-
Tavor, S.1
Petit, I.2
Porozov, S.3
Avigdor, A.4
Dar, A.5
Leider-Trejo, L.6
Shemtov, N.7
Deutsch, V.8
Naparstek, E.9
Nagler, A.10
Lapidot, T.11
-
6
-
-
67650367598
-
Targeting the leukemia microenvironment byCXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
-
Zeng Z, Shi YX, Samudio IJ, et al. Targeting the leukemia microenvironment byCXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood. 2009;113(24):6215-6224.
-
(2009)
Blood
, vol.113
, Issue.24
, pp. 6215-6224
-
-
Zeng, Z.1
Shi, Y.X.2
Samudio, I.J.3
-
7
-
-
57849163583
-
The CXCR4 antagonist AMD3100 impairs survivalofhuman AML cells and induces their differentiation
-
Tavor S, Eisenbach M, Jacob-Hirsch J, et al. The CXCR4 antagonist AMD3100 impairs survivalofhuman AML cells and induces their differentiation. Leukemia. 2008;22(12):2151-5158.
-
(2008)
Leukemia
, vol.22
, Issue.12
, pp. 2151-5158
-
-
Tavor, S.1
Eisenbach, M.2
Jacob-Hirsch, J.3
-
8
-
-
67650410440
-
Chemosensitization of acute myeloid leukemia (AML) following mobilization bythe CXCR4 antagonist AMD3100
-
Nervi B, Ramirez P, Rettig MP, et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization bythe CXCR4 antagonist AMD3100. Blood. 2009; 113(24):6206-6214.
-
(2009)
Blood
, vol.113
, Issue.24
, pp. 6206-6214
-
-
Nervi, B.1
Ramirez, P.2
Rettig, M.P.3
-
9
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335-2342. (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
10
-
-
33846241600
-
CXCR4 is a prognostic marker in acute myelogenous leukemia
-
DOI 10.1182/blood-2006-05-024844
-
Spoo AC, Lubbert M, Wierda WG, Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood. 2007;109(2):786-791. (Pubitemid 46105982)
-
(2007)
Blood
, vol.109
, Issue.2
, pp. 786-791
-
-
Spoo, A.C.1
Lubbert, M.2
Wierda, W.G.3
Burger, J.A.4
|